Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Synthesis and biological evaluation of imidazopyridine-oxindole conjugates as microtubule-targeting agents.

Kamal A, Reddy VS, Karnewar S, Chourasiya SS, Shaik AB, Kumar GB, Kishor C, Reddy MK, Narasimha Rao MP, Nagabhushana A, Ramakrishna KV, Addlagatta A, Kotamraju S.

ChemMedChem. 2013 Dec;8(12):2015-25. doi: 10.1002/cmdc.201300308. Epub 2013 Sep 23.

PMID:
24115733
[PubMed - indexed for MEDLINE]
2.

Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17.

Vaibhava V, Nagabhushana A, Chalasani ML, Sudhakar C, Kumari A, Swarup G.

J Cell Sci. 2012 Nov 1;125(Pt 21):5026-39. doi: 10.1242/jcs.102327. Epub 2012 Aug 1.

PMID:
22854040
[PubMed - indexed for MEDLINE]
Free Article
3.

Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation.

Nagabhushana A, Bansal M, Swarup G.

PLoS One. 2011 Mar 7;6(3):e17477. doi: 10.1371/journal.pone.0017477.

PMID:
21408173
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Optineurin, a multifunctional protein involved in glaucoma, amyotrophic lateral sclerosis and antiviral signalling.

Swarup G, Nagabhushana A.

J Biosci. 2010 Dec;35(4):501-5. No abstract available.

PMID:
21289430
[PubMed - indexed for MEDLINE]
Free Article
5.

Regulation of endocytic trafficking of transferrin receptor by optineurin and its impairment by a glaucoma-associated mutant.

Nagabhushana A, Chalasani ML, Jain N, Radha V, Rangaraj N, Balasubramanian D, Swarup G.

BMC Cell Biol. 2010 Jan 19;11:4. doi: 10.1186/1471-2121-11-4.

PMID:
20085643
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

NF-kappaB mediates tumor necrosis factor alpha-induced expression of optineurin, a negative regulator of NF-kappaB.

Sudhakar C, Nagabhushana A, Jain N, Swarup G.

PLoS One. 2009;4(4):e5114. doi: 10.1371/journal.pone.0005114. Epub 2009 Apr 2.

PMID:
19340308
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk